Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
1.660
-0.160 (-8.79%)
Aug 14, 2025, 11:33 AM - Market open
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$3,232,667
Market Cap
4.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDT News
- 9 days ago - Conduit to Change Name to CDT Equity Inc. - GlobeNewsWire
- 5 weeks ago - Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy - GlobeNewsWire
- 5 weeks ago - Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - GlobeNewsWire